TP63 and neoplasm: Our previous studies have established TP63 as an SCC-specific master regulator TF27,28,32, and the specific expression profile of TP63 in SCCs was validated at the pan-cancer level using RNA-seq data of human tumor samples from The Cancer Genome Atlas (TCGA) (Supplementary Fig. 1A).